CA2030232A1 - Test serologique en phase solide - Google Patents
Test serologique en phase solideInfo
- Publication number
- CA2030232A1 CA2030232A1 CA 2030232 CA2030232A CA2030232A1 CA 2030232 A1 CA2030232 A1 CA 2030232A1 CA 2030232 CA2030232 CA 2030232 CA 2030232 A CA2030232 A CA 2030232A CA 2030232 A1 CA2030232 A1 CA 2030232A1
- Authority
- CA
- Canada
- Prior art keywords
- porous member
- antibodies
- fluid
- binding
- test sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003556 assay Methods 0.000 title claims abstract description 53
- 239000007790 solid phase Substances 0.000 title abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 79
- 238000000034 method Methods 0.000 claims abstract description 55
- 238000012360 testing method Methods 0.000 claims abstract description 33
- 208000035473 Communicable disease Diseases 0.000 claims abstract description 16
- 208000015181 infectious disease Diseases 0.000 claims abstract description 9
- 239000000427 antigen Substances 0.000 claims abstract description 8
- 102000036639 antigens Human genes 0.000 claims abstract description 8
- 108091007433 antigens Proteins 0.000 claims abstract description 8
- 239000012530 fluid Substances 0.000 claims description 37
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 239000000758 substrate Substances 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 238000012216 screening Methods 0.000 claims description 8
- 101710120037 Toxin CcdB Proteins 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 5
- 239000003365 glass fiber Substances 0.000 claims description 4
- 239000012857 radioactive material Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 230000005670 electromagnetic radiation Effects 0.000 claims 1
- 230000001678 irradiating effect Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 10
- 238000001514 detection method Methods 0.000 abstract description 5
- 239000000243 solution Substances 0.000 description 22
- 239000000523 sample Substances 0.000 description 19
- 241000725303 Human immunodeficiency virus Species 0.000 description 8
- 239000013610 patient sample Substances 0.000 description 8
- 238000005406 washing Methods 0.000 description 5
- 239000011358 absorbing material Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000001000 lipidemic effect Effects 0.000 description 3
- 229920002113 octoxynol Polymers 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 241000598436 Human T-cell lymphotropic virus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 101000654316 Centruroides limpidus Beta-toxin Cll2 Proteins 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 101000985498 Mus musculus Hermansky-Pudlak syndrome 4 protein homolog Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44502589A | 1989-12-01 | 1989-12-01 | |
| US445,025 | 1989-12-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2030232A1 true CA2030232A1 (fr) | 1991-06-02 |
Family
ID=23767336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2030232 Abandoned CA2030232A1 (fr) | 1989-12-01 | 1990-11-19 | Test serologique en phase solide |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0456794A1 (fr) |
| AU (1) | AU647428B2 (fr) |
| CA (1) | CA2030232A1 (fr) |
| WO (1) | WO1991008485A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1105181A (zh) * | 1993-04-14 | 1995-07-12 | 国际莫莱斯技术公司 | 免疫测定法 |
| GB2282884A (en) * | 1993-04-14 | 1995-04-19 | Int Murex Tech Corp | Immunoassay |
| US5478753A (en) * | 1993-06-29 | 1995-12-26 | Pb Diagnostic Systems, Inc. | Positive calibrator/control composition for an IgM serology assay and an IgM serology assay |
| ATE551605T1 (de) * | 2007-07-30 | 2012-04-15 | Univ Arizona | Verfahren und vorrichtungen zur erkennung von biofilmen |
| EP2335073A4 (fr) | 2008-09-02 | 2012-09-26 | Univ Maryland | Diagnostic d'infection de biofilm in vivo et traitement |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4273756A (en) * | 1978-07-28 | 1981-06-16 | Abbott Laboratories | Immunoassay for class specific antibodies |
| DE2965570D1 (en) * | 1978-08-24 | 1983-07-07 | Akzo Nv | Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination |
| US4292403A (en) * | 1978-08-24 | 1981-09-29 | Akzona Incorporated | Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins |
| DE3026665A1 (de) * | 1980-07-14 | 1982-02-11 | Hoechst Ag, 6000 Frankfurt | Verfahren zum binden und trennen fuer den kompetitiven radioimmunoassay und reagenz hierzu |
| WO1987006345A1 (fr) * | 1986-04-11 | 1987-10-22 | Murex Corporation | Immuno-annalyse de mesure colorimetrique de proportionnalite |
| AU610095B2 (en) * | 1986-11-19 | 1991-05-16 | Genetic Systems Corporation | Membrane affinity concentration immunoassay |
| DE3705686C2 (de) * | 1987-02-23 | 1995-11-30 | Boehringer Mannheim Gmbh | Verfahren zur Bestimmung von Antikörpern |
| US4857453A (en) * | 1987-04-07 | 1989-08-15 | Syntex (U.S.A.) Inc. | Immunoassay device |
| DE3717401A1 (de) * | 1987-05-23 | 1988-12-08 | Behringwerke Ag | Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel |
| US4981786A (en) * | 1987-09-04 | 1991-01-01 | Syntex (U.S.A.) Inc. | Multiple port assay device |
| DE3879048T2 (de) * | 1987-09-11 | 1993-09-02 | Abbott Lab | Geraet fuer die laterale immunochromatographische bestimmung. |
| AU3696289A (en) * | 1988-06-08 | 1990-01-05 | Cambridge Bioscience Corporation | Anti-fc assay for detection of antibodies |
| BR9105168A (pt) * | 1990-03-28 | 1992-08-04 | Tenta Properties Nv | Processo para a coleta de anticorpos e deteccao de uma especie de anticorpo especifica em uma amostra fluida,complexo nao toxico,nao infeccioso,dispositivo compreendendo um veiculo que contem o complexo e kit para realizar dosagens imunodiagnosticas |
-
1990
- 1990-11-15 EP EP19900917732 patent/EP0456794A1/fr not_active Withdrawn
- 1990-11-15 AU AU67598/90A patent/AU647428B2/en not_active Ceased
- 1990-11-15 WO PCT/US1990/006680 patent/WO1991008485A1/fr not_active Ceased
- 1990-11-19 CA CA 2030232 patent/CA2030232A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU647428B2 (en) | 1994-03-24 |
| EP0456794A1 (fr) | 1991-11-21 |
| AU6759890A (en) | 1991-06-26 |
| WO1991008485A1 (fr) | 1991-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0180638B1 (fr) | Procede et appareil pour des analyses immunologiques | |
| US5824268A (en) | Rapid self-contained assay format | |
| AU748387B2 (en) | Neutralization of polycations in a chromatographic device for whole blood use | |
| JP3758814B2 (ja) | サンドイッチ免疫測定法における応答シグナルの増幅方法 | |
| US7135329B2 (en) | Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients | |
| US5478753A (en) | Positive calibrator/control composition for an IgM serology assay and an IgM serology assay | |
| US6121008A (en) | Chromatographic immunoassay device and method utilizing particle valency for quantification | |
| US7507550B2 (en) | Analytical sandwich test for determining NT-proBNP | |
| EP3425399A1 (fr) | Dispositif de dosage immunologique à double trajet | |
| JPH0627738B2 (ja) | 特異的結合アッセイ装置および方法 | |
| JPH0312705B2 (fr) | ||
| JPH01140066A (ja) | 指示流診断装置および方法 | |
| AU647428B2 (en) | Immunoassay for antibodies to infectious disease agents | |
| US7109023B2 (en) | Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients | |
| CA2008100A1 (fr) | Methode de dosage de substances detectables par des methodes immunologique | |
| JPH05126832A (ja) | 免疫分析装置及び免疫分析方法 | |
| CN112740039A (zh) | 免疫层析试验片 | |
| WO1991018291A1 (fr) | Support solide comprenant des anticorps immobilises sur sa surface | |
| JPH04203968A (ja) | 化学発光免疫測定法 | |
| JPH05503772A (ja) | 固相血清学的検定方法 | |
| KR910001313B1 (ko) | 면역 분석 방법 및 장치 | |
| JPH09229938A (ja) | 抗梅毒トレポネーマ抗体の免疫分析方法及び免疫分析装置 | |
| JPH07218438A (ja) | 測定対象物の定量法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |